Miklasińska-Majdanik Maria
Department of Microbiology and Virology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.
Antibiotics (Basel). 2021 Nov 17;10(11):1406. doi: 10.3390/antibiotics10111406.
Methicillin resistant strains pose a serious treatment problem because of their multi-drug resistance (MDR). In staphylococcal strains, resistance to macrolides, lincosamides, and streptogramin B (MLS) correlates with resistance to methicillin. The rapid transmission of genes responsible for MLS resistance has strongly limited the clinical application of traditional macrolides such as erythromycin. On the other hand, in the age of increasing insensitivity to antibiotics the idea of implementing a therapy based on older generation drugs brings hope that the spread of antibiotic resistance will be limited. A thorough understanding of the resistance mechanisms contributes to design of antibiotics that avoid bacterial insensitivity. This review highlights the mechanisms of action of macrolides and mechanism of resistance to these antibiotics among .
耐甲氧西林菌株因其多重耐药性(MDR)而带来严重的治疗难题。在葡萄球菌菌株中,对大环内酯类、林可酰胺类和链阳菌素B(MLS)的耐药性与对甲氧西林的耐药性相关。负责MLS耐药性的基因快速传播,极大地限制了传统大环内酯类药物如红霉素的临床应用。另一方面,在对抗生素敏感性日益降低的时代,实施基于老一代药物的治疗方案这一想法带来了抗生素耐药性传播将得到限制的希望。深入了解耐药机制有助于设计出能避免细菌耐药的抗生素。本综述重点介绍了大环内酯类药物的作用机制以及其中对这些抗生素的耐药机制。